SYNGENE.NS
Syngene International Ltd
Price:  
629.45 
INR
Volume:  
1,102,961.00
India | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SYNGENE.NS WACC - Weighted Average Cost of Capital

The WACC of Syngene International Ltd (SYNGENE.NS) is 13.3%.

The Cost of Equity of Syngene International Ltd (SYNGENE.NS) is 13.50%.
The Cost of Debt of Syngene International Ltd (SYNGENE.NS) is 5.75%.

Range Selected
Cost of equity 12.10% - 14.90% 13.50%
Tax rate 18.10% - 19.70% 18.90%
Cost of debt 4.00% - 7.50% 5.75%
WACC 11.9% - 14.7% 13.3%
WACC

SYNGENE.NS WACC calculation

Category Low High
Long-term bond rate 6.9% 7.4%
Equity market risk premium 8.3% 9.3%
Adjusted beta 0.63 0.76
Additional risk adjustments 0.0% 0.5%
Cost of equity 12.10% 14.90%
Tax rate 18.10% 19.70%
Debt/Equity ratio 0.02 0.02
Cost of debt 4.00% 7.50%
After-tax WACC 11.9% 14.7%
Selected WACC 13.3%

SYNGENE.NS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for SYNGENE.NS:

cost_of_equity (13.50%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.63) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.